Peripheral nerve injuries represent a major cause of morbidity and disability worldwide, as well as lead to substantial costs to society at individual and national lev-els. It has been estimated that peripheral nerve injuries affect 2.8% of all trauma patients, many of whom acquire life-long disability.
1 The annual incidence of peripheral nerve injuries in developed countries has been reported as 13 to 23 out of 100,000 persons. [2] [3] [4] Recovery following severe peripheral nerve injury is often dismal despite the inherent capability for axonal regeneration.
3 Autologous nerve grafts are considered the gold standard treatment in cases of nerve defect, although often not providing satisfactory results. Moreover, autolo-gous nerve donor may cause related neurological morbid-ity at the donor site, including possible neuroma formation. 5 The gold standard autograft repair of the damaged peripheral nerve is far from optimal and is often disap-pointing. 6 Interposition of nerve scaffold 7 whether cellu-lar allograft or an artificial acellular conduit 8 is an alternative procedure to the use of grafts. Most repair scaffolds consist of a hollow tube made of polymeric materials such as silicone, biologic materials such as col-lagen, or biodegradable polymers. 5, [9] [10] [11] [12] [13] The use of nerve guidance channels (tubes), sutured in between the proxi-mal and distal nerve stumps, has been actively pursued to obviate the need for the second procedure at the donor site and to obtain better regenerative results in compari-son to the autologous nerve graft. Entubulation repair cause less surgical trauma at the repair site, 14 and may decrease the possibility for neuroma formation. More-over, guidance channels may assist in directing axons from the proximal to the distal stump without any inter-ference from imperfectly aligned degenerating fascicles of the nerve graft or the closely apposed distal stump and reduce axonal staggering.
14 Guidance channels mini-mize the infiltration of fibrous scar tissue, which may further hinder axonal regeneration, [15] [16] [17] while at the same time maximize the accumulation of soluble factors produced by the nerve stumps, and may also act as scaf-folds for different filling materials which can further sup-port regeneration. Nevertheless, tubulization with simple guides usually fails when bridging relatively long gaps of 6 mm in mice, 18, 19 15 mm in rats 20 and 30 mm in prima-tes. 21, 22 There are several hollow nerve tubes currently available for clinical use, which are applied for repair of small-diameter nerves with nerve defects of up to 2-3 cm. [23] [24] [25] [26] These nerve tubes (including Neurotube [Synovis; polyglycolic acid], Neuro-lac [Ascension; poly lac-tide-co-e-caprolactone], and Neura-Gen [Integra; type-I collagen]) are made of different biomaterials and there-fore differ in their physical properties. Due to the small nerve diameter and limited length, these conduits are clinically used for the repair of digital nerve injuries and do not benefit the majority of patients suffering from severe peripheral nerve injury. Severe nerve injuries with massive loss defect are currently treated with autograft repair, however, despite the advanced microsurgical tech-niques, functional recovery is far from being optimal and often disappointing.
27 Therefore, innovative regenerative therapies for injured peripheral nerve that simultaneously potentiate axonal regeneration, promote selective target reinnervation and modulate central reorganization are needed. 28 This study investigates, from a pre-clinical per-spective, an artificial nerve device designed to reconstruct injured peripheral nerves.
MATERIALS AND METHODS
This study was performed in accordance with approved protocols by the Institutional Animal Care and adhered strictly to the Animal Care guidelines. The ani-mals were housed 2 per cage with a 12-hour light/dark cycle, with free access to food and water.
Preparation of Chitosan Tube
Chitosan is partially or fully deacetylated form of chi-tin, which is found widely in nature in the exoskeletons of arthropods, shells of crustaceans, the cuticles of insects and the cell walls of fungi. 29, 30 It is made up of b(1!4) linked D-glucosamine and N-acetyl-D-glucosamine sub units. It is used in biomedical applications because of its biocompatibility, low toxicity, biodegradability, and struc-tural similarity to natural glycosaminoglycans.
Chitosan-based scaffolds, developed and manufac-tured by Medovent GmbH, Germany, were used in this study.
Experiment Design and Surgical Technique
The model for this in vivo study consisted of 21 female Wistar rats, weighing 200-250 g each. The rats were oper-ated to establish a complete sciatic nerve defect of 10 mm, immediately followed by nerve reconstruction employing composite chitosan-based hollow tube (n 5 11) or autolo-gous nerve graft (n 5 10). General anesthesia was induced with intra-peritoneal injection of xylazine (15 mg) and ketamine (50 mg) . The procedure was performed using a high magnification surgical microscope.
In group I, the left sciatic nerve was exposed and separated from biceps femoris and semimembranosus muscles beginning from the area of branches to the glutei and hamstring muscles and distally to the trifurcation into peroneal, tibial, and sural nerves. The sciatic nerve was then transected and a 5 mm nerve segment was removed. A 12 mm chitosan hollow tube was placed between the proximal and the distal parts of the trans-ected nerve for reconstruction, enabling the nerve to enter the tube 1 mm on each side, while providing a 10 mm gap between the proximal and distal ends. Two 9-0 non-absorbable sutures were used to anchor the tube to the epineurium at the proximal and distal nerve stumps (Fig. 1) . The muscular, subcutaneous and skin layers were closed. In group II, the left sciatic nerve was exposed as described above and then sharply incised with micro scis-sors at the femur level below the superior gluteal nerve and above the division of the sciatic nerve to the tibial nerve and the peroneal nerve. A nerve segment of 10 mm was inverted. Immediately thereafter, end-to-end coaptation was performed using 2 to 3 non-absorbable 10-0 sutures. Coaptation of nerve fascicles was carried out to preserve all the fascicles within the epineural sac. The muscular, subcutaneous and skin layers were closed.
Pre-operative evaluation and post-operative follow-up was performed and consisted of functional motor assess-ment of the sciatic nerve utilizing SFI, electrophysiologi-cal assessment of nerve conductivity, applying SSEP studies and CMAP. All assessment of SFI, SSEP, and CMAP were carried out in a blinded manner without dis-closure of the different groups to the evaluating team.
During the observational period, imaging studies employ-ing ultrasonography were carried out for evaluation of nerve regeneration inside the chitosan hollow tubes.
Sciatic functional index. SFI is a widely described test which helps to evaluate the functionality of operated sciatic nerve in rats in compared to the opposite intact limb.31-36 The rat was placed on a paper track after dipping the hind limbs in non-toxic ink. The imprints from the ambulating hind limbs enabled us to measure the maximal footprint length (PL), maximal distance between fingers 1-5 (IT) and fingers 2-4 (TS), from both normal (N) and operated (E) legs. The SFI value was calculated using Bain's formula.37
All rats were evaluated for SFI at baseline (prior to surgery), as well as at 30 and 90 days after surgical reconstruction. The data were collected in a blinded man-ner and the groups were revealed to the examiner only after completion of the study.
Electrophysiology. Electrophysiology studies, SSEPs and CMAPs, were recorded using the Dantec "KEYPOINT" workstation. Conductivity of the sciatic nerve and spinal cord was studied by stimulation of the sci-atic nerve at the level of the tarsal joint with simultaneous recording from the skull over the somatosensory cortex. The SSEP recordings were performed on all rats in a blinded manner before surgery and at 30 and 90 days fol-lowing the surgical procedure. During the electrophysio-logical study the rats were anesthetized using xylazine (15 mg) and ketamine (50 mg). Two subcutaneous needle electrodes were inserted under the skin of the scalp with the active electrode over the somatosensory cortex along the midline and reference electrode between the eyes. The ground electrode was placed subcutaneously on the dorsal back. The sciatic nerve was stimulated by two polarized electrodes placed on the lateral aspect of the tarsal joint. An average was generated of at least three hundred stimulation pulses of 0.1 msec in duration at a rate of 3 Hz. The stimu-lus intensity was set on 1.5-3.5 mA until a slight twitching of the limb was noted. The appearance of an evoked poten-tial in two consecutive tests as a response to a stimulus was considered positive. Since SSEP pose substantial technical difficulties and more subjected to variations of anesthesia and level of central synaptic efficacy,38 CMAP was added at 90 days to aid and validate electrophysiological studies. CMAP testing was performed on left hind limb and just prior to harvesting of the reconstructed nerves. CMAPs were done by applying supra-maximal stimulation (maxi-mal response120%) of the proximal sciatic nerve with electrodes placed at the sciatic notch and recording electro-des in the gastrocnemius muscle.
The data were collected in a blinded manner and the groups were revealed to the examiner only after comple-tion of the study.
Ultrasound imaging . Ultrasound imaging enables in vivo periodic assessment of the tube. All rats were anesthetized during the sonographic examination. Ultra-sound examinations were performed on a unit equipped with color Doppler capabilities using 7-15 MHz linear transducer yielding an axial resolution of 0.2-0.4 mm. The sonographic scanning technique included longitudi-nal and transverse sections with a standard scanning gel. Identification of the chitosan tube on the ultrasound image was based on the recognition of a hyper-echoic structure of tubular shape in the longitudinal axis and circular shape on transverse section. This imaging modality has not been previously described for realtime in vivo evaluation of peripheral nerve-tube reconstruction. In this work we utilized ultrasonography for evaluation of the proximal and distal nerve stumps, integrity of the implanted chitosan tube, the nerve-tube relationship and demonstration of tissue proliferation inside the chitosan tube. Ultrasonography was used for imaging of the chito-san reconstruction group at 30 and 90 days after surgery. Histology and morphometrical analysis. Regen-erated sciatic nerve samples were harvested and fixed for 2 hour in a solution of 2.5% glutaraldehyde in Sorensen buffer 0.1M added with 0,5% sucrose. Samples were then washed in Sorensen buffer 0.1M added with 1,5% sucrose, post-fixed in 2% osmium tetroxide, dehydrated with ethanol and embedded in a mixture of Araldite res-ins following Glauerts' procedure.
The distal part of sciatic nerve samples were processed 5 mm distally to the area of neurorrhaphy (tube or distal nerve coaptation) for quantitative morphometry of myelin-ated nerve fibers. Series of 2-mm thick semi-thin transverse sections were cut using a Leica Ultracut UCT ultramicro-tome (Leica Microsystems, Wetzlar, Germany) and stained by Toluidine blue. Stereology was carried out on a DM4000B microscope equipped with a DFC320 digital camera and an IM50 image manager system (Leica Micro-systems, Wetzlar, Germany). Systematic random sampling and D-dissector were adopted using a protocol previously described.39 Total fiber number, fibers' and axons' diame-ter and myelin thickness were estimated. Muscle weight assessment. Immediately following harvest of the regenerated nerve tissue, the gastrocnemius muscle was removed on both sides (intact and operated hind limbs) and the wet muscle weight was recorded. Statistical analysis. Data analysis was carried out on all 21 rats; 11 rats underwent reconstruction using chitosan tube, and 10 rats were treated according to auto-logous nerve graft reconstruction model. Statistical analy-sis and calculations were done using MatLab software (Ver. 2008b, The MathWorks, Inc.). Non-parametric sta-tistics were used in this study. Hence, all figures are pre-sented with Median 6 Mad. All significance levels were calculated using a Mann-Whitney U test and a Wilcoxon signed-rank test. SSEP responses were analyzed as cate-gorical parameters using v2 test.
RESULTS
For evaluation of nerve reconstruction using chitosan hollow tube versus standard of care reconstruction with autologous nerve graft, we have used the following research measures: behavioral (SFI), electrophysiological (SSEP, CMAP), nerve imaging studies (US), histomor-phometrical analysis, and muscle weights. To identify ongoing changes, we have conducted measurements at different time periods (0, 30, and 90 days).
Maintenance of bodyweight or rate of weight gain is one of the indicators of an animal's state of health. 40 We have found that 30 days after surgery the rats weight gain was minimal (6 g, 10.5 g; P 5 0.413), which might indicate stress related to the postsurgical healing process. After this initial phase, the rats continued gaining weight (19.5 g versus 22.5 gr; P 5 0.338) until the end of the experiment (45 gr vs. 55.4 gr; P 5 0.172). This weight gaining tendency was found to be identical in both chitosan tube and autologous nerve graft groups (Fig. 2) . SFI showed no statistically significant difference between the chitosan tube reconstruction (group 1) and autologous nerve graft (group 2) groups both at the 30-days point (287.1 6 9.1 vs. 284.5 6 14.5, P 5 0.177, respectively) and the 90-days point (274.2 6 16.9 vs. 266.8 6 10.7, P 5 0.486, respectively).
Both groups presented the same pattern of recovery, with about half showing some SSEP activity at 30 days (45% group 1 vs. 44% group 2, P 5 0.96). One rat from group 2 was not included in this evaluation. At 90 days, most rats (91% group 1 vs. 80% group 2, P 5 0.46) showed SSEP activity. CMAP testing was carried out 90 days after surgery. No statistically significant difference was found between the groups both in latency (1.39 ms vs. 1.63 ms; P 5 0.48) and amplitude (6.28 mv vs. 6.43 mv; P 5 0.8).
Ultrasonography imaging performed during the obser-vational period demonstrated progressive tissue growth inside the tube and no signs of conduit collapse or com-pression along the postoperative period (Fig. 3) . The operated sciatic nerve was exposed 90 days after surgery (Fig. 4) . The corresponding gastrocnemius muscle was harvested for evaluation of muscle weight. As expected, there was significant difference in gastrocnemius muscle weight between operated left limb and the intact right limb (0.6 vs. 1.3, P < 0.001). No statistically significant difference was noted between the study group (chitosan hollow tube) and the control group (autologous nerve graft) (0.7 vs. 0.6, P 5 0.3) (Fig. 5) .
Representative high resolution light micrographs of semi-thin sections of the regenerated sciatic nerves are shown in Figure 6 . Axonal regeneration occurred in both experimental groups (A: autograft, B: chitosan tube) with good regeneration pattern. Toluidine blue stained trans-verse nerve sections showed microfascicles typical of regenerated nerves. Figure 7 shows the results of the stereological assessment of myelinated fibers number (A) and diameter, myelin thickness and g-ratio (B) in the two experimental groups. The total number of myelinated nerve fibers was comparable between the two groups (P_0.005) (15867 63318 in the autograft group vs. 15,30262,872 in the chitosan group). Also the size parameters were not statistically different between the two experimental groups (P _0.05) (fiber diameter: 3.75 6 0.36 vs. 3.41 6 0.25; myelin thickness: 0.65 6 0.05 vs. 0.65 6 0.02; g-ratio: 0.58 6 0.24 vs. 0.57 6 0.11). 
DISCUSSION
Peripheral nerve injuries are a significant cause of mor-bidity. Despite the inherent ability of the peripheral nerv-ous system to regenerate, functional recovery after severe nerve injury is often unsatisfactory. Biohybrid project, con-sisting of research and development groups across Europe, was established with the aim of developing an implant that will promote better nerve regeneration, which will allow functional recovery without the need of harvesting nerve for transplant. 41, 42 The purpose of this study, conducted as part of the Biohybrid project, was to evaluate reconstruc-tion of nerve loss with chitosan hollow tube compared to the accepted standard of care reconstruction consisting of autologous nerve grafting. The main focus was to provide pre-clinical evidence from the perspective of clinical employment of chitosan hollow tubes.
Previous research publications using various tubes for nerve reconstruction, and some of which are in clinical use, demonstrated functional recovery. 7, 9, 26, 43 The required properties of an optimal nerve conduit should be biodegradable, permeable, flexible but noncollapsible, simple to handle and suture, transparent and capable of being sterilized without compromising its physical prop-erties. 26 Some of the limitations of artificial nerve con-duits relate to the absence of Schwann cells to support nerve regeneration which are present in the nerve auto-graft. Also hollow tubes lack internal supporting struc-tures which may facilitate nerve growth. Chitosan is an attractive material because of its mechanical strength, transparency, porosity, biodegradability, and biocompatibility without causing inflammatory response which may impair regeneration.30,44 Several stud-ies have referred to the potential benefits of chitosan in the design of controlled drug release systems.45,46 The excel-lent biocompatibility of chitosan, together with its specific interaction with components of the extracellular matrix and growth factors, led to its use in tissue engineering.47 It was also observed that due to its cationic nature, chitosan covalently coupled to agarose gel enhanced neurite exten-sion from dorsal root ganglia. and phrenic nerve (n 5 3) in beagle dogs and concluded that C-tubes can facilitate the regeneration of damaged sympathetic and phrenic nerves and restore lost functions.52 Patel et al. evaluated functional recovery of sciatic nerves in rats repaired with chitosan nerve guide using video assisted gait analysis.53 Other outcome measurements included histology and muscle weight. The authors concluded that based on video-gait analysis, histology and muscle weight improved functional recovery was seen as a result of the use of chitosan nerve guides. Finally, a recent study by Gonzalez-Perez et al. showed that chitosan tubes may permit regeneration also for longer gap in the rat model.54 Two clinical case reports utilizing chitosan tube for reconstruction of the median nerve were published.55,56 Fan et al. described repair of a 3.5-cm long median nerve defect at the elbow using chitosan/polyglycolic acid nerve conduit.55 The same group reported again on repair of a 3-cm long median nerve defect in the distal forearm using the same nerve conduit.56 In both cases, three years later, improvement in motor and sensory function was noted. These two case reports do not add significant evidence to support routine clinical use of chitosan tubes due to the scientific limitation of these studies.
In the current study, we evaluate functional recovery and histomorphometrical outcome of chitosan tube reconstruction versus autograft repair and this is the first experimental study where imaging study was utilized in order to demonstrate the relationship between the implanted tube and regenerating tissue during the observational period. In vivo real-time imaging allows assessment of the physical properties of the implanted material, including tube detachment, collapse of the scaf-fold and external compression.
In this study, it has been demonstrated that after 90 days, functional and electrophysiological outcomes were comparable between the chitosan tube reconstruction group and autologous nerve graft group. Muscle weight assessment and histomorphometry also demonstrated comparable results in the two groups with similar axon numbers and myelin thickness. Ultrasonography of the chitosan tube during the observational period did not identify detachment of the tube and neural stumps, nor external tissue compression or collapse. Nerve growth inside the tube was identified after 90 days.
Real-time imaging utilizing ultrasonography is under-used in the experimental environment considering its added value for evaluating the relationship of the recon-structed nerve and surrounding tissue, and its relative availability.
CONCLUSION
This study evaluated nerve regeneration through chi-tosan tube versus autologous nerve graft and found no statistically significant difference. Peripheral nerve recon-struction of the sciatic nerve in rats using chitosan hol-low tubes is comparable with gold standard autologous nerve graft, with the inherent potential of treating large nerve gaps and also functioning as a scaffold for filling material which may support nerve regeneration.
Further study, currently being performed, will focus on nerve regeneration utilizing chitosan tube with differ-ent filling materials.
